Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy
Low immunogenicity and immunosuppressive tumor microenvironment (TME) are two pivotal factors restricting tumor immunotherapy. Photodynamic therapy (PDT) directly destroys cancer cells by producing reactive oxygen species (ROS), and enhances the immunogenicity of ''cold'' tumors...
Saved in:
Main Authors: | Tao Xu, Kehan Liu, Shuqi Mi, Yao Yao, Mengyao Zhang, Shujuan Xue, Feng Zhi, Sally-Ann Cryan, Dawei Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-04-01
|
Series: | Materials Today Bio |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425000882 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Participation of COX2/mPGES1/PGE2 in mouse and human endometrial stromal decidualization
by: Peng-Chao Wang, et al.
Published: (2025-01-01) -
Nrf2/cyclooxygenase 2 signaling in Cr(VI)-induced carcinogenesis
by: Lei Zhao, et al.
Published: (2025-02-01) -
Improving ferroptosis-mediated immunotherapy for colorectal cancer through lysosome-targeted photodynamic therapy
by: Zhian Chen, et al.
Published: (2025-04-01) -
Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation
by: Chisato Yamada, et al.
Published: (2025-01-01) -
Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin<sup>−/−</sup>/Utrophin<sup>−/−</sup> Double-Knockout Mice
by: Xueqin Gao, et al.
Published: (2025-01-01)